What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the orthopedic treatment of hyaluronic acid injection market?

Increasing demand for non-surgical treatments and rising awareness of hyaluronic acid injections.

What are the challenges facing the orthopedic treatment of hyaluronic acid injection market?

High costs and limited reimbursement policies are major challenges.

Which regions are leading the orthopedic treatment of hyaluronic acid injection market?

North America and Europe are the leading regions due to high adoption rates.

Who are the top companies in the orthopedic treatment of hyaluronic acid injection market?

Key players include Sanofi, Johnson & Johnson, and Pfizer.

What are the future opportunities in the orthopedic treatment of hyaluronic acid injection market?

Emerging markets and increasing use of hyaluronic acid in sports medicine offer future opportunities.

What is the current regulatory landscape for the orthopedic treatment of hyaluronic acid injection market?

Regulatory bodies are implementing strict guidelines for product approval and safety.

What is the future outlook for the orthopedic treatment of hyaluronic acid injection market size?

The market is expected to reach USD 2.5 billion by 2033, driven by increasing demand.

How Big Is the orthopedic treatment of hyaluronic acid injection Market? Size, Share & Forecast 2033

orthopedic treatment of hyaluronic acid injection by Application (Hospitals, Clinics, Others), by Types (Single Injection, Three Injection, Five Injection), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $8.6 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $8.6 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

orthopedic treatment of hyaluronic acid injection Market Size | CAGR 7.8 Forecast 2033

How Big Is the orthopedic treatment of hyaluronic acid injection Market? Size, Share & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $8.6 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $8.6 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

orthopedic treatment of hyaluronic acid injection Market Overview

The orthopedic treatment of hyaluronic acid injection market refers to the use of hyaluronic acid injections to treat orthopedic conditions, such as osteoarthritis. As the orthopedic treatment of hyaluronic acid injection market size is expected to grow, it is essential to understand the growth outlook, market forecast, and industry expansion. The scope of this market includes the use of hyaluronic acid injections for various orthopedic applications, including viscosupplementation and joint pain relief. The current orthopedic treatment of hyaluronic acid injection market size is approximately $3.5 billion, with a growth forecast of 8-10% CAGR during the forecast period. The market is driven by macro drivers such as the increasing prevalence of osteoarthritis, the rising demand for non-surgical treatments, and the growing awareness of hyaluronic acid injections as a viable treatment option.

Loading chart…

The orthopedic treatment of hyaluronic acid injection market is shaped by key forces such as technology shifts, with the development of new injection technologies and products, regulations, with the increasing scrutiny of hyaluronic acid injections by regulatory bodies, and consumer behavior, with the growing demand for non-surgical and minimally invasive treatments. The largest region for this market is North America, while the fastest-growing region is Asia-Pacific. As the market continues to evolve, it is essential for industry players to stay ahead of the curve and adapt to the changing landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	8.60 million
Revenue forecast in 2033	15.68 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sanofi; Anika Therapeutics; Seikagaku; Zimmer Biomet; Bioventus; Ferring; LG Chem; Freda; Haohai Biological; Shanghai Jingfeng
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The orthopedic treatment of hyaluronic acid injection market is experiencing significant growth, driven by various factors. The market dynamics are influenced by several key elements that impact the orthopedic treatment of hyaluronic acid injection market size and growth forecast.

Growth Drivers2 items

Increasing demand for non-surgical treatments for osteoarthritis and other orthopedic conditions is driving the adoption of hyaluronic acid injections, leading to a rise in the orthopedic treatment of hyaluronic acid injection market size.

Advances in technology and the development of more effective hyaluronic acid products are expanding the range of treatment options available, contributing to the growth forecast of the market.

Restraints2 items

High costs associated with hyaluronic acid injections and limited reimbursement coverage in some regions are constraining market growth and affecting the orthopedic treatment of hyaluronic acid injection market size.

Stringent regulatory requirements and varying approval processes across different countries are creating challenges for manufacturers and impacting the growth forecast of the market.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America offer significant opportunities for growth, driven by increasing awareness and demand for orthopedic treatments, which is expected to contribute to the growth forecast of the orthopedic treatment of hyaluronic acid injection market.

Partnerships and collaborations between manufacturers, research institutions, and healthcare providers can facilitate the development of new products and technologies, further driving the growth of the market and increasing the orthopedic treatment of hyaluronic acid injection market size.

Challenges2 items

Intense competition among manufacturers and the presence of generic products are putting pressure on prices, affecting revenue and profitability in the orthopedic treatment of hyaluronic acid injection market.

Ensuring the quality and safety of hyaluronic acid products, particularly in the face of increasing regulatory scrutiny, is a significant challenge that manufacturers must address to maintain market credibility and support the growth forecast.

Market Segmentation

Loading chart…

The orthopedic treatment of hyaluronic acid injection market can be segmented based on application, which refers to the specific uses of hyaluronic acid injections in treating various orthopedic conditions. This segmentation category contributes to the overall market size by highlighting the different areas where hyaluronic acid injections are most effective, such as osteoarthritis, tendonitis, and ligament sprains. Understanding the application segment is crucial for market taxonomy and identifying opportunities for growth in the orthopedic treatment of hyaluronic acid injection segmentation.

Another significant segmentation category in the orthopedic treatment of hyaluronic acid injection market is types, which includes subtypes such as single-injection cycle and three-injection cycle. This segmentation category is essential in determining the overall market size, as it affects the demand for different types of hyaluronic acid injections. For instance, single-injection cycle products may be more popular among patients who prefer convenience, while three-injection cycle products may be preferred by those who require more prolonged treatment. Analyzing the types segment is vital for understanding the orthopedic treatment of hyaluronic acid injection market dynamics.

orthopedic treatment of hyaluronic acid injection Segmentation Breakdown8 items

Application

Hospitals

Clinics

Others

Types

Single Injection

Three Injection

Five Injection

Regional Insights

Loading chart…

The orthopedic treatment of hyaluronic acid injection market is expected to witness significant growth in various regions. North America is the largest region, accounting for approximately 40% of the market share, driven by high adoption rates of hyaluronic acid injections, favorable policies, and substantial investments in orthopedic research. Key drivers in North America include increasing demographic demand, advanced infrastructure, and a mature ecosystem.

The Asia Pacific region is the fastest-growing, with a regional forecast indicating a significant increase in market share. This growth can be attributed to rising awareness of hyaluronic acid injections, improving infrastructure, and growing investments in healthcare. Europe also holds a significant share, driven by established healthcare systems and high demand for orthopedic treatments. Latin America and the Middle East & Africa are expected to witness moderate growth, driven by increasing adoption and expanding healthcare infrastructure.

Key factors driving the orthopedic treatment of hyaluronic acid injection market growth include adoption rates, policies, and investments. The market is expected to witness significant growth in the coming years, with the Asia Pacific region leading the way. As the market continues to evolve, it is essential to monitor regional forecast and market trends to capitalize on emerging opportunities.

Competitive Landscape

The orthopedic treatment of hyaluronic acid injection competitive landscape is moderately consolidated, with a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The market is driven by companies seeking to differentiate themselves through innovative products and strong distribution networks, with the orthopedic treatment of hyaluronic acid injection key players focusing on building a robust product portfolio.

Companies in this market employ various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks, which can impact their ability to maintain a strong market presence.

Sanofi: regional expansion

Anika Therapeutics: innovation pipeline

Seikagaku: premium pricing

Zimmer Biomet: vertical integration

Bioventus: OEM tie-ups

Ferring: local manufacturing

Key orthopedic treatment of hyaluronic acid injection Companies10 items

Sanofi

Anika Therapeutics

Seikagaku

Zimmer Biomet

Bioventus

Ferring

LG Chem

Freda

Haohai Biological

Shanghai Jingfeng

Market Ecosystem

The orthopedic treatment of hyaluronic acid injection ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, midstream, and downstream, with value created and captured as it flows through each stage, from raw materials to finished products and ultimately to end users. Understanding this ecosystem is crucial for conducting a thorough value chain analysis.

Raw material suppliers — providing hyaluronic acid

OEMs/manufacturers — producing injection devices

Technology providers — developing injection technologies

Distributors/channel partners — delivering products to healthcare providers

Service providers/after-sales — offering support and maintenance services

End users/buyers — healthcare providers and patients

Regulators/standards bodies — establishing safety and efficacy standards

In the orthopedic treatment of hyaluronic acid injection ecosystem, control points are primarily held by regulators and standards bodies, who influence adoption through approvals and standards. Dependency risks include input constraints, such as the availability of high-quality hyaluronic acid, and regulatory approvals. Switching costs are relatively high due to the specialized nature of the products and the need for interoperability with existing healthcare infrastructure. The ecosystem may differ by region due to varying regulatory requirements and healthcare systems, leading to distinct market dynamics in different areas.

Recent Industry Insights

The orthopedic treatment of hyaluronic acid injection industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between major pharmaceutical companies and research institutions, have driven innovation in the field. Notable mergers and acquisitions have also taken place, with companies expanding their product portfolios and strengthening their market presence.

Furthermore, the launch of new products and technologies has improved treatment outcomes for patients. Regulatory changes have also had an impact, with updated guidelines and approvals influencing the industry's trajectory. A shift in consumer trends has been observed, with an increasing preference for minimally invasive procedures and personalized treatment options. Additionally, funding rounds and expansions have enabled companies to invest in research and development, propelling the orthopedic treatment of hyaluronic acid injection industry trends forward.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the orthopedic treatment of hyaluronic acid injection market. The market attractiveness is moderate, driven by an aging population and increasing demand for non-surgical treatments. The competitive intensity is high, with several major players competing for market share. The long-term orthopedic treatment of hyaluronic acid injection market outlook is positive, with expected growth driven by innovation and increasing adoption of hyaluronic acid injections.

The innovation landscape is rapidly evolving, with new products and technologies being developed to improve treatment outcomes. However, the demand-supply balance is a key risk factor, as supply chain disruptions and regulatory challenges can impact market growth. Overall, the market offers opportunities for growth, but companies must navigate the competitive landscape and manage key risk factors to succeed.

12 items

1. Executive Summary

2. orthopedic treatment of hyaluronic acid injection Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global orthopedic treatment of hyaluronic acid injection Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global orthopedic treatment of hyaluronic acid injection Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global orthopedic treatment of hyaluronic acid injection Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global orthopedic treatment of hyaluronic acid injection Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global orthopedic treatment of hyaluronic acid injection Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global orthopedic treatment of hyaluronic acid injection Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global orthopedic treatment of hyaluronic acid injection Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global orthopedic treatment of hyaluronic acid injection Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global orthopedic treatment of hyaluronic acid injection Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global orthopedic treatment of hyaluronic acid injection Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global orthopedic treatment of hyaluronic acid injection Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global orthopedic treatment of hyaluronic acid injection Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global orthopedic treatment of hyaluronic acid injection Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global orthopedic treatment of hyaluronic acid injection Market Competition by Key Manufacturers

9.1. Global orthopedic treatment of hyaluronic acid injection Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global orthopedic treatment of hyaluronic acid injection: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Sanofi

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Anika Therapeutics

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Seikagaku

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Zimmer Biomet

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Bioventus

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Ferring

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. LG Chem

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Freda

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Haohai Biological

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Shanghai Jingfeng

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global orthopedic treatment of hyaluronic acid injection Market

Figure 4: Global orthopedic treatment of hyaluronic acid injection Market: Drivers

Figure 5: Global orthopedic treatment of hyaluronic acid injection Market: Challenges

Figure 6: Global orthopedic treatment of hyaluronic acid injection Market: Trends

Figure 7: Global orthopedic treatment of hyaluronic acid injection Market: Opportunity

Figure 8: Global orthopedic treatment of hyaluronic acid injection Market: Restraint

Figure 9: Global orthopedic treatment of hyaluronic acid injection Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global orthopedic treatment of hyaluronic acid injection Market Value (USD Million) By Region

Figure 19: Global orthopedic treatment of hyaluronic acid injection Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global orthopedic treatment of hyaluronic acid injection Market Value (USD Million) By Region

Figure 27: Global orthopedic treatment of hyaluronic acid injection Market Share (%) By: Regions (2032)

Figure 28: Global orthopedic treatment of hyaluronic acid injection Market Volume (K) By Region

Figure 29: Global orthopedic treatment of hyaluronic acid injection Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global orthopedic treatment of hyaluronic acid injection Market Value (USD Million) By Region

Figure 37: Global orthopedic treatment of hyaluronic acid injection Market Share (%) By: Regions (2032)

Figure 38: Global orthopedic treatment of hyaluronic acid injection Market Volume (K) By Region

Figure 39: Global orthopedic treatment of hyaluronic acid injection Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global orthopedic treatment of hyaluronic acid injection Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global orthopedic treatment of hyaluronic acid injection Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global orthopedic treatment of hyaluronic acid injection Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global orthopedic treatment of hyaluronic acid injection Market Value (USD Million) By Region

Table 14: Global orthopedic treatment of hyaluronic acid injection Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global orthopedic treatment of hyaluronic acid injection Market Volume (K) By Region

Table 31: Global orthopedic treatment of hyaluronic acid injection Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global orthopedic treatment of hyaluronic acid injection Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global orthopedic treatment of hyaluronic acid injection Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global orthopedic treatment of hyaluronic acid injection Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Sanofi Basic Information And Sales Area

Table 52: Sanofi. Products Portfolio

Table 53: Anika Therapeutics Basic Information And Sales Area

Table 54: Anika Therapeutics. Products Portfolio

Table 55: Seikagaku Basic Information And Sales Area

Table 56: Seikagaku. Products Portfolio

Table 57: Zimmer Biomet Basic Information And Sales Area

Table 58: Zimmer Biomet. Products Portfolio

Table 59: Bioventus Basic Information And Sales Area

Table 60: Bioventus. Products Portfolio

Table 61: Ferring Basic Information And Sales Area

Table 62: Ferring. Products Portfolio

Table 63: LG Chem Basic Information And Sales Area

Table 64: LG Chem. Products Portfolio

Table 65: Freda Basic Information And Sales Area

Table 66: Freda. Products Portfolio

Table 67: Haohai Biological Basic Information And Sales Area

Table 68: Haohai Biological. Products Portfolio

Table 69: Shanghai Jingfeng Basic Information And Sales Area

Table 70: Shanghai Jingfeng. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global orthopedic treatment of hyaluronic acid injection Market Value (USD Million) By Region

Table 80: Global orthopedic treatment of hyaluronic acid injection Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global orthopedic treatment of hyaluronic acid injection Market Volume (K) By Region

Table 97: Global orthopedic treatment of hyaluronic acid injection Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

orthopedic treatment of hyaluronic acid injection Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.60 million
Revenue forecast in 2033	15.68 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sanofi; Anika Therapeutics; Seikagaku; Zimmer Biomet; Bioventus; Ferring; LG Chem; Freda; Haohai Biological; Shanghai Jingfeng
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options